The analysis, released April 20, predicted U.S. vaccine enthusiasm will reach a tipping point in two to four weeks.
The prediction is based on Americans’ recent attitudes toward receiving COVID-19 vaccines. KFF’s most recent poll showed that as of March 21, 61 percent of Americans have either already received a COVID-19 vaccine or want to get vaccinated as soon as possible, up from 55 percent the previous month. That increase comes primarily from Americans who have shifted from a “wait and see” attitude to vaccine enthusiasm, according to KFF.
That 61 percent of Americans (157 million adults) will be vaccinated by May 5 if the U.S. maintains its current vaccination pace, which is about 1.7 million doses per day. If more Americans move from the “wait and see” group to the vaccine-enthusiastic group, it could take a week or two longer for the U.S. to administer shots to its residents who want COVID-19 vaccines.
Without widespread vaccine acceptance, the U.S. faces a significant challenge to reaching herd immunity, the point when enough Americans are immune to the novel coronavirus that it can no longer spread throughout the population. Once the vaccine-enthusiastic population receives their shots, the country will face more difficulty in its efforts to encourage COVID-19 vaccinations.
More articles on pharmacy:
J&J reports $100M in COVID-19 vaccine sales
Congress investigating Emergent BioSolutions’ vaccine contracts
Over-the-counter COVID-19 tests now at CVS, Walgreens
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
